Sponsor intelligence · OTHER
Clinical trials sponsored by
Sun Yat-Sen University.
Real, source-linked trial activity for Sun Yat-Sen University: 9 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Nov 3, 2026. Source-linked, daily-refreshed.
PHASE2 5NA 2PHASE3 1N/A 1
Newest Sun Yat-Sen University trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 6d ago | A Phase III Randomized Controlled Trial of Serplulimab Plus Fruquintin | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 9d ago | A Single-Arm, Open-Label, Multicenter Clinical Study of Teniposide Com | NA | NOT_YET_RECRUITING | ↗ |
| 15d ago | Becotatug Vedotin + Pucotenlimab+Platinum Induction and Sequential CCR | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 21d ago | HR20013 for the Prevention of Nausea and Vomiting in Patients With Can | N/A | RECRUITING | ↗ |
| 21d ago | Prospective Phase II Study of Concurrent Radiotherapy Combined With Fu | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 22d ago | Lenvatinib Plus Bevacizumab and PD-1 Inhibition Versus Bevacizumab Plu | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 28d ago | A Phase II Study of Anlotinib + PD-1 Inhibitor vs. PD-1 Inhibitor Main | Ph 2 | RECRUITING | ↗ |
| 36d ago | Cryoablation Combined With Hepatic Arterial Infusion of Iparomlimab an | Ph 2 | RECRUITING | ↗ |
| 47d ago | Multi-Theory Model-Based AI Agent Intervention for Smoking Cessation i | NA | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Sun Yat-Sen University (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.